SH3TC2
protein-codingSH3 domain and tetratricopeptide repeats 2, the group of MicroRNA protein coding host genes|Tetratricopeptide repeat domain containing
Gene summary
This gene encodes a protein with two N-terminal Src homology 3 (SH3) domains and 10 tetratricopeptide repeat (TPR) motifs, and is a member of a small gene family. The gene product has been proposed to be an adapter or docking molecule. Mutations in this gene result in autosomal recessive Charcot-Marie-Tooth disease type 4C, a childhood-onset neurodegenerative disease characterized by demyelination of motor and sensory neurons. [provided by RefSeq, Jul 2008]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~139.5 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0011113
Submitter: ClinGen
SH3TC2 was first reported in relation to autosomal recessive hereditary demyelinating motor and sensory neuropathy in 2003 (Senderek et al., PMID:14574644). It is mainly characterized by a sensory-motor demyelinating neuropathy with onset typically in childhood. Early-onset scoliosis is present in a large number of patients. SH3TC2 has been noted to be associated with the following disease entities: Charcot-Marie-Tooth disease, type 4C (OMIM: 601596) and Mononeuropathy of the median nerve, mild (OMIM: 613353). Per criteria outlined by the ClinGen Lumping and Splitting Working Group, we found differences in inheritance pattern AND phenotypic variability. Therefore, the disease entities have been Split. About 80 variants have been reported, including missense and nonsense variants. The maximum score for genetics evidence has been reached (12 points). Evidence supporting the gene-disease relationship includes case-level variant evidence and experimental data. Hela cells transfected with SH3TC2 mutants fail to co-localize with RAB11 at recycling endosomes and co-immunoprecipitation assay confirmed loss of protein-protein interaction with RAB11 in the mutants. SH3TC2 mutants fail to induce membrane receptor internalization in transfected cells compared to wild-type (Gouttenoire et al., PMID: 23553667). Therefore, the mechanism for pathogenicity appears to be loss-of-function. A knockout mouse model for SH3TC2 developed progressive peripheral neuropathy, mimicking the human phenotype (Arnaud et a., PMID: 19805030). Nerve biopsy shows severe hypomyelination in the knockout mice. The mice phenotype was rescued with a lentivirus expressing the human SH3TC2 cDNA, which was delivered intrathecally (Schiza et al., PMID: 30907403). In summary, SH3TC2 is definitively associated with autosomal recessive hereditary demyelinating motor and sensory neuropathy. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time.
Inheritance Pattern: AR
Disease ID:MONDO:0013237
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0013237
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0011113
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0011113
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0013237
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0011113
Submitter: Ambry Genetics
Clinical Genomic Database (CGD)
Manifestation: Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to SH3TC2 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_024577.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 5 | 304 | 8 | 318 | |
| missense | 24 | 578 | 97 | 1 | 700 | |
| nonsense | 43 | 20 | 4 | 67 | ||
| start loss | 1 | 1 | ||||
| frameshift | 41 | 22 | 14 | 77 | ||
| splice donor/acceptor (+/-2bp) | 7 | 18 | 2 | 27 | ||
| Total | 92 | 85 | 603 | 401 | 9 | 1190 |
Highest pathogenic variant AF is 0.0010427419
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_078853.2 | 17 | MANE Select | |
| Ensembl | ENSP00000423660.1 | 17 | MANE Select | |
| Ensembl | ENSP00000313025.5 | 7 | Standard | |
| Ensembl | ENSP00000421092.2 | 6 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Biological Process
- peripheral nervous system myelin maintenance
- regulation of intracellular protein transport
- regulation of ERBB signaling pathway
Cellular Component
- plasma membrane
- cytoplasmic vesicle
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000515425
- Coding exons
- 17
- Length
- 139525
- Individuals with no LoFs
- 125451
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 297
- Defined
- 125748
- p
- 0.00118
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -0.713 | 721 | 669 | 1.08 | 0.0000386 | 8347 |
| Missense (PolyPhen) | 188 | 187.03 | 1.0052 | 2425 | ||
| Synonymous | -1.40 | 307 | 277 | 1.11 | 0.0000151 | 2631 |
| Loss of Function | 2.67 | 33 | 54.3 | 0.608 | 0.00000274 | 663 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00080 | 0.00080 | rare |
| Latino/Admixed American | 0.00038 | 0.00038 | rare |
| Ashkenazi Jewish | 0.000099 | 0.000099 | rare |
| East Asian | 0.00033 | 0.00033 | rare |
| Finnish | 0.00069 | 0.00069 | rare |
| European (Non-Finnish) | 0.0018 | 0.0018 | notable |
| South Asian | 0.0011 | 0.0011 | notable |
| Other | 0.0018 | 0.0018 | notable |
dbNSFP Gene Annotations
Source:
- Disease
- DISEASE: Mononeuropathy of the median nerve mild (MNMN) [MIM:613353]: A disease characterized by median nerve mononeuropathy at the wrist. The clinical presentation ranges from a mild phenotype, consistent with carpal tunnel syndrome, to a severe median nerve mononeuropathy at the wrist associated with evidence of a more widespread axonal polyneuropathy. The latter phenotype is similar to that of patients with hereditary neuropathy with liability to pressure palsies. {ECO:0000269|PubMed:20220177}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.139
Intolerance Scores
- LoFtool
- 0.477
- RVIS EVS
- 0.02
- RVIS percentile EVS
- 55.23
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.368
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |